Interpreting measures of treatment effect in cancer clinical trials

Oncologist

Volumn 7, Issue 3, 2002, Pages 181-187

  Case, L Douglas ^a   Kimmick, Gretchen ^a   Paskett, Electra D ^a   Lohman, Kurt ^a   Tucker, Robert ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Hazard ratio; Odds ratio; Relative risk; Survival; Tumor response

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT;

ARTICLE; ASSAY; CANCER; CANCER CHEMOTHERAPY; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; HAZARD ASSESSMENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PUBLICATION; REGRESSION ANALYSIS; RISK; RISK ASSESSMENT; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

CLINICAL TRIALS; DISEASE PROGRESSION; ENDPOINT DETERMINATION; HUMANS; NEOPLASMS; ODDS RATIO; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 0036073237     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.7-3-181     Document Type: Article

References (21)

1. Odds and odds ratio: An odd confusion
2. An odd measure of risk: Use and misuse of the odds ratio
3. Logistic regression analysis: When the odds ratio does not work - An example using intimate partner violence data
4. Odds ratios should be avoided when events are common
5. Clinically useful measures of effect in binary analyses of randomized trials
6. When can odds ratios mislead?
7. Down with odds ratios!
8. Choice of effect measure for epidemiological data
9. Odds ratio or relative risk for cross-sectional data
10. Covariance adjustment of rates based on the multiple logistic regression model
11. What is the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes
12. Digesting logistic regression results
13. Nonparametric estimation from incomplete observations
14. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
15. Regression models and life-tables